abcellera is a canadian biotechnology company focused on accelerating the discovery of monoclonal antibody (mabs) therapeutics.   antibodies are molecules that are naturally produced by the immune system of humans or animals to fight off infection and dise

AbCellera Biologics Inc. Common Shares

Sold short ABCL

This member connected a brokerage account and is sharing trades and portfolio performance with the community. 

Public Portfolio

John Procopio

Bought to close all ABCL

Bought to close 78% ABCL

Sold all ABCL

Abilash Satya

Sold 50% of ABCL

Bought 100% more ABCL

New position in ABCL

Alex Roznowski

Bought 14% more ABCL

Bought 8% more ABCL

Bought 18% more ABCL

Bought 10% more ABCL

Bought 25% more ABCL

Bought 17% more ABCL

Bought 20% more ABCL

Bought 33% more ABCL

Bought 50% more ABCL